News
India fintech app Dezerv raises $21m Series A
Accel has led a USD 21m Series A round for Indian retail investment services app Deserv with support from existing investors Elevation Capital and Matrix Partners India.
Carlyle CEO Kewsong Lee steps down
Kewsong Lee has resigned as CEO of The Carlyle Group just over two years since assuming the role on a solo basis, with co-founder Bill Conway taking over in an interim capacity.
New Zealand's GreenMount seeks $69m for co-investment fund
GreenMount Capital, an investment unit of New Zealand-based GreenMount Advisory, is looking to raise up to NZD 100m (USD 69.2m) for its debut private equity co-investment fund that will participate in deals in Australia and New Zealand.
Australia's Genesis makes biolabs investment
Genesis Capital, a mid-market Australian private equity firm specialising in healthcare, has acquired a majority stake in Crux Biolabs, a contract research organisation (CRO) based in the Melbourne suburbs.
Ex-EQT partner wins funding for Asia ESG services platform
Tak Wai Chung, who until early last year was a Singapore-based partner at EQT, has secured funding for a pan-Asian platform that will provide software solutions to corporates that need to meet environment, social, and governance (ESG) requirements.
Adamantem to carve out cardiology unit from Australia's GenesisCare
Adamantem Capital has agreed to acquire Australia’s largest cardiology services provider through as a carve-out from KKR-backed healthcare giant GenesisCare.
Thailand's SCB 10X appoints Mukaya Panich as CEO
SCB 10X, the VC arm of Thailand’s Siam Commercial Bank, has appointed Mukaya Panich, its chief investment and venture officer, as CEO.
China biotech company GluBio raises $22m
China and US-based GluBio Therapeutics, which develops targeted protein degradation (TPD) drugs, has raised an extended Series A round of USD22m led by Qiming Venture Partners.
Uber, Tiger make Zomato realisations
Uber has fully exited its stake in India-based food services platform Zomato, which completed a domestic IPO just over 12 months ago, while Tiger Global has sold down part of its position.
India's WebEngage gets $20m Series B
Singularity Growth Opportunities Fund and SWC Global have led a USD 20m Series B round for WebEngage, an India-based start-up specialising in customer retention and relationship management.
Japan satellite data, metaverse start-up raises $11m
Japanese VCs have provided a JPY 1.4bn (USD 11m) seed round for SpaceData, a start-up that uses earth imaging data from satellites to create virtual 3D environments replicating the real world.
Proparco commits $25m to India's Northern Arc
French development finance institution Proparco has invested USD 25m in debt in India’s Northern Arc Capital, a microfinance and small business lender with several private equity backers.
Bain targets $5b for fifth Asia fund
Bain Capital has launched its fifth Asia-focused private equity fund with a target of USD 5bn. It comes a couple of months after the firm closed its latest regional special situations vehicle on USD 2bn.
Australia hydrogen player gets $29m Series A
Australia’s Virescent Ventures, a VC firm spun out earlier this year from Clean Energy Finance Corporation (CEFC), has led a AUD 40m (USD 29m) Series A round for local hydrogen energy start-up Hysata.
ADIA, GIC lead $300m round for China's Taibang Biologic
Taibang Biologic Group, a specialist in blood plasma-based pharmaceuticals formerly known as China Biologic Products, has raised a USD 300m round led by Abu Dhabi Investment Authority (ADIA) and GIC.
Sarmaycar, Shorooq back Pakistan fintech player OneLoad
OneLoad, a Pakistan-based digital financial services platform established by local IT player Systems Limited and the International Finance Corporation (IFC), has raised USD 11m in funding.
Allegro buys New Zealand fuel retail business
Australia’s Allegro Funds has agreed to acquire 100% of petrol station chain Gull New Zealand, the largest independent operator of its kind locally, for NZD 552m (USD 327m).
China biotech player Sironax raises $200m Series B
Gaorong Capital and Yunfeng Capital have led a USD 200m Series B round for China’s Sironax, a drug developer targeting age-related degenerative diseases.
Qiming, Quan lead $120m Series B for China's OriCell
Qiming Venture Partners and Quan Capital have led a USD 120m Series B round for OriCell Therapeutics, a China-based drug developer that is working on CAR-T cell therapies that target cancer.
Omnivore exits India agtech player Eruvaka
Indian agriculture technology specialist Omnivore Partners claims to have achieved the country’s largest exit in the sector to date with the sale of aquaculture start-up Eruvaka to Dutch strategic Nutreco.
Singapore's Singtel pumps $100m into VC arm
Singapore telecom giant SingTel has committed USD 100m to its VC arm Innov8. The investment unit, which operates on an evergreen fund model, has received USD 350m to date.
Creador backs Philippines digital bank
Creador has made a rare early-stage investment, leading a pre-Series A round of USD 11m for UnoAsia, operator of Uno Digital Bank, one of only six licensed digital banks in the Philippines.
China's Ribo Life Science raises $40m as part of Series E
Chinese drug developer Suzhou Ribo Life Science has raised USD 40m in the first tranche of a Series E from existing investors Panlin Capital and Trinity Innovation Fund. Several undisclosed new investors also took part.
Affirma supports Korea's NPX in Terapin Studios deal
Affirma Capital has confirmed a USD 38m investment in Terapin Studios, a US-based media platform controlled by Korea’s NPX Capital focused on bringing Korean digital comics to global markets.